Journal of Clinical Oncology | 2019

Increasing potency and safety of anticancer drugs through sortilin receptor-mediated cancer therapy: A new targeted approach for the treatment of ovarian cancer.

 
 
 
 
 
 

Abstract


e17068Background: The development of personalized therapies against ovarian cancer remains highly challenging in current modern oncology. One strategy to achieve greater selectivity and better anti...

Volume 37
Pages None
DOI 10.1200/JCO.2019.37.15_SUPPL.E17068
Language English
Journal Journal of Clinical Oncology

Full Text